5
Hiran Orgochem Ltd
506170 BSE
Hiran Orgochem Ltd
Healthcare BSE: 506170 Pharmaceuticals & Biotechnology
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Company has reduced debt.
Weaknesses
3- The company has delivered a poor sales growth of -70.9% over past five years.
- Company has high debtors of 322 days.
- Working capital days have increased from 1,638 days to 2,355 days
Growth Rate
Revenue Growth
-100.00% →
Net Income Growth
103.00% →
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-
Quarterly Results
| Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.22 | 2.56 | 0.09 | 0 | 0.24 | 0 | 0.14 | 0.05 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 40.07 | 2.76 | 0.3 | 6.04 | 0.34 | 0.14 | 0.3 | 30.29 | 0 | 0.11 | -0.34 | 0.12 | 0.06 |
| Operating Profit | -35.85 | -0.2 | -0.21 | -6.04 | -0.1 | -0.14 | -0.16 | -30.24 | 0 | -0.11 | 0.34 | -0.12 | -0.06 |
| OPM % | -849.53% | -7.81% | -233.33% | — | -41.67% | — | -114.29% | -60480% | — | — | — | — | — |
| Other Income | 1.62 | 0.27 | 0.27 | 0.38 | 0 | 0.02 | 0.11 | 0.69 | 0 | 0 | 0 | 0.93 | 0 |
| Interest | 0.01 | 0 | 0 | 0.18 | 0 | 0 | 0 | -0.07 | 0 | 0 | 0 | 0.06 | 0 |
| Depreciation | 0.58 | 0.62 | 0.62 | 0.27 | 0 | 0 | 0 | 0.05 | 0 | 0.03 | 0.01 | 0.01 | 0.01 |
| PBT | -34.82 | -0.55 | -0.56 | -6.11 | -0.1 | -0.12 | -0.05 | -29.53 | 0 | -0.14 | 0.33 | 0.74 | -0.07 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — | 0% | 0% | 0% | 0% |
| Net Profit | -34.82 | -0.55 | -0.56 | -6.11 | -0.1 | -0.12 | -0.05 | -29.53 | 0 | -0.14 | 0.33 | 0.73 | -0.07 |
| EPS in Rs | -3.53 | -0.06 | -0.06 | -0.62 | -0.01 | -0.01 | -0.01 | -2.99 | 0 | -0.01 | 0.03 | 0.07 | -0.01 |
Profit & Loss
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 15m | Jun 2012 | Jun 2013 9m | Mar 2014 | Mar 2015 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 113 | 108 | 119 | 188 | 203 | 148 | 38.91 | 23.96 | 2.62 | 0.42 | 0 |
| Expenses | 88.58 | 100 | 108 | 203 | 190 | 215 | 50.99 | 82.59 | 9.08 | 8.32 | -0.05 |
| Operating Profit | 24.13 | 7.65 | 11.71 | -14.73 | 12.86 | -67.23 | -12.08 | -58.63 | -6.46 | -7.9 | 0.05 |
| OPM % | 21.41% | 7.09% | 9.81% | -7.82% | 6.34% | -45.51% | -31.05% | -244.7% | -246.56% | -1880.95% | — |
| Other Income | 1.08 | 1.83 | 2.67 | 1.62 | 9.07 | 2.81 | 7.64 | 1.47 | 0.93 | -19.79 | 0.93 |
| Interest | 3.62 | 5.18 | 7.57 | 9.99 | 9.09 | 15.22 | 1.9 | 0.08 | 0.18 | 0.01 | 0.06 |
| Depreciation | 1.26 | 1.62 | 1.83 | 2.12 | 2.33 | 3.2 | 2.76 | 2.77 | 1.51 | 0.05 | 0.06 |
| PBT | 20.33 | 2.68 | 4.98 | -25.22 | 10.51 | -82.84 | -9.1 | -60.01 | -7.22 | -27.75 | 0.86 |
| Tax % | 34.19% | 59.7% | 22.09% | -31.09% | 29.12% | 0.65% | 0% | 0% | 0% | 0% | — |
| Net Profit | 13.38 | 1.08 | 3.88 | -17.38 | 7.45 | -83.38 | -9.09 | -60.01 | -7.22 | -27.76 | 0.85 |
| EPS in Rs | 3.47 | 0.21 | 0.74 | -3.31 | 1.42 | -8.45 | -0.92 | -6.08 | -0.73 | -2.81 | 0.08 |
| Div. Payout % | 8.65% | 48.61% | 13.53% | -1.21% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Mar 2014 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.72 | 10.5 | 10.5 | 10.5 | 52.5 | 98.66 | 98.66 | 98.66 | 98.66 | 98.66 |
| Reserves | 39.34 | 73.69 | 76.96 | 61 | 26.44 | -56.94 | -66.03 | -126 | -133 | -161 |
| Borrowings | 32.75 | 47.89 | 56.67 | 51.62 | 53.7 | 96.15 | 89.05 | 88.76 | 85.71 | 65.45 |
| Other Liabilities | 39.81 | 44.35 | 57.5 | 65.66 | 89.66 | 55.67 | 30.87 | 25.48 | 24.5 | 22.41 |
| Total Liabilities | 120 | 176 | 202 | 189 | 222 | 194 | 153 | 86.86 | 75.61 | 25.5 |
| Fixed Assets | 27.56 | 31.68 | 35.95 | 36.53 | 37.04 | 38.78 | 35.58 | 33.08 | 31.57 | 0.2 |
| CWIP | 1.22 | 0.57 | 2.27 | 1.26 | 0.14 | 0.04 | 0.04 | 0.04 | 0 | 0 |
| Investments | 1.52 | 0.78 | 0.89 | 2.9 | 4.8 | 4.69 | 4.69 | 4.59 | 4.59 | 0 |
| Other Assets | 89.32 | 143 | 163 | 148 | 180 | 150 | 112 | 49.15 | 39.45 | 25.3 |
| Total Assets | 120 | 176 | 202 | 189 | 222 | 194 | 153 | 86.86 | 75.61 | 25.5 |
Cash Flow
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Mar 2014 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -17.59 | -41 | 4.58 | 20.73 | 11.9 | -56.67 | 9.59 | -28.64 | -0.92 | -16.08 |
| Investing | -9 | -3.24 | -6.58 | -2.6 | -1.29 | -1.1 | 2.28 | 1.11 | 0.96 | 16.13 |
| Financing | 27.23 | 45.84 | 1.87 | -15.32 | -8.97 | 73.97 | -9.01 | -0.34 | 0 | 0 |
| Net Cash Flow | 0.64 | 1.6 | -0.13 | 2.81 | 1.64 | 16.2 | 2.86 | -27.87 | 0.04 | 0.05 |
| Free Cash Flow | -24.83 | -46.04 | -3.23 | 18.49 | 9.98 | -61.78 | 9.88 | -28.63 | -0.87 | -5.42 |
| CFO/OP | -56 | -496 | 48 | -144 | 94 | 84 | -81 | 51 | 14 | 204 |
Ratios
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Mar 2014 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 63.67 | 58.46 | 89.01 | 34.31 | 74.58 | 73.47 | 186 | 119 | 1,159 | 322 |
| Inventory Days | 205 | 260 | 262 | 105 | 147 | 23.77 | 39.69 | 17.12 | 154 | 930 |
| Days Payable | 133 | 131 | 189 | 124 | 161 | 89.83 | 266 | 350 | 3,212 | 17,598 |
| Cash Conversion Cycle | 136 | 188 | 162 | 15.34 | 60.32 | 7.42 | -40.42 | -214 | -1,899 | -16,347 |
| Working Capital Days | 159 | 331 | 319 | 138 | 145 | 170 | 498 | 359 | 2,062 | 2,355 |
| ROCE % | — | 7.34% | 9.09% | -11.37% | 15.48% | -49.65% | -5.31% | -65.43% | -8.16% | -26.09% |
Documents
5
Disclosure under Reg. 30 of SEBI (LODR) Regulations, 2015
31 Aug 2016 - Hiran Orgochem Ltd has informed BSE regarding Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015. 31 Aug 2016 - Hiran Orgochem Ltd has informed BSE regarding Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015.
Frequently Asked Questions about Hiran Orgochem Ltd
What does Hiran Orgochem Ltd do?
Hiran Orgochem is a leading integrated manufacturer of active pharmaceutical ingredients and formulations.
Where is Hiran Orgochem Ltd (506170) listed?
Hiran Orgochem Ltd is listed on the Indian stock exchanges. It is listed on BSE: 506170. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Hiran Orgochem Ltd belong to?
Hiran Orgochem Ltd operates in the Healthcare sector within the Pharmaceuticals & Biotechnology industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
How can I research Hiran Orgochem Ltd on Tapetide?
On Tapetide, you can view Hiran Orgochem Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Hiran Orgochem is a leading integrated manufacturer of active pharmaceutical ingredients and formulations.